Moderna had been leading one of the companies providing booster shots to the people. The food and drug administration, also known as the FDA, have stated that people who are over the age of 18 can get booster shots in the United States.
But the time period had been changed a bit with the reduction of one month. The Moderna vaccine had to be taken as a booster shot within 5 months of the primary vaccine.
The fact is that you are not sufficiently protected against the omicron variant of the coronavirus. You have to take the booster shot. The first shots are effective, but they are just 75% effective against the virus. This is not just a random number.
FDA has researched this, and then they have taken a calculated decision. The booster shots time period had been reduced by one month for the sake of the people.
The vaccines are indeed a blessing because, without them, many people will be dying because of the omicron variant of the coronavirus.
Read Also:
- New Study Gives Hope for Treatment of PBC
- Fully Vaccinated Families Can ‘Feel Good’ About Gatherings, Says Fauci
- UK Extends Covid Booster Vaccines to the Over-40s
- US Will Distribute Johnson & Johnson Vaccine in Conflict Zones, Blinken Says
If you are thinking that it’s no use taking the booster shots, then you are wrong. You need to take the booster shot.
“Vaccination is our best defense against Covid-19, including the circulating variants, and shortening the length of time between completion of a primary series and a booster dose may help reduce waning immunity,” said Dr. Peter Marks. If you don’t know who he is, he is the head of the FDA group responsible for vaccine safety.
We are hoping that you take the shot on time and be safe with your near and dear ones. Take care of yourself.
Contents
Is the Moderna Vaccine FDA Approved?
Yes, the Moderna COVID-19 vaccine, also known as mRNA-1273, initially received Emergency Use Authorization (EUA) from the FDA in December 2020 for individuals aged 18 and older.
Following extensive review and positive data from ongoing clinical trials showing high efficacy and safety standards, the Moderna vaccine was granted full FDA approval in January 2022 for the same age group.
Did the FDA Approve the New COVID Booster?
The FDA has approved the use of a booster dose for the Moderna COVID-19 vaccine under the EUA, particularly in response to evolving research and data regarding vaccine efficacy over time and against various variants.
The booster approval was initially targeted at older adults and other high-risk populations but has since been extended to a broader demographic based on new safety and efficacy findings.
How Long to Wait for Booster Vaccine?
With the latest update from the FDA, individuals who have received the Moderna vaccine are now recommended to wait only five months before receiving a booster shot, shortened from the previously advised six months.
This adjustment is based on scientific evidence suggesting that a booster at five months provides a timely enhancement to immunity, especially in the context of emerging variants like Omicron, which may partially evade initial vaccine protection.
Are All Vaccines FDA Approved?
Not all vaccines available globally are FDA approved or authorized. Within the United States, vaccines must undergo rigorous testing and evaluation by the FDA to ensure they meet safety and efficacy standards before they receive EUA or full approval.
Currently, vaccines from Pfizer-BioNTech, Moderna, and Johnson & Johnson have received FDA authorization for emergency use, with Pfizer-BioNTech and Moderna also receiving full FDA approval for certain age groups.
Additional Details on Moderna Booster and Vaccine Protocols
- Booster Eligibility: Initially, booster shots were recommended for individuals 65 and older, adults at high risk of severe COVID-19, and those in high-exposure settings. With the threat of new variants and additional data supporting the safety of boosters, the FDA has expanded eligibility to all adults five months post their initial vaccination series.
- Vaccine Effectiveness: Both the initial Moderna vaccine series and the booster shot have shown high effectiveness in preventing severe disease, hospitalization, and death from COVID-19. Studies indicate that while vaccine effectiveness may wane over time, a booster significantly enhances protection.
- Public Health Impact: The shortened waiting period for the Moderna booster is part of broader efforts to increase protection against COVID-19 as new variants spread. Increasing booster uptake is critical to mitigating the impact of the pandemic and returning to normalcy.
Conclusion
The FDA’s decision to shorten the waiting period for the Moderna booster to five months reflects an agile response to the dynamic nature of the COVID-19 pandemic and emerging scientific data.
This update is crucial for individuals looking to maintain high levels of immunity against the virus.
As the situation evolves, staying informed through reliable sources and adhering to updated vaccination guidelines will be key to navigating the ongoing health crisis effectively.
